340 related articles for article (PubMed ID: 31775088)
21. Identification of two novel BCKDHA mutations in a Chinese patient with maple syrup urine disease.
Wang J; Liu H; Chen G; Tsuei SH; Yu T; Fu Q
J Pediatr Endocrinol Metab; 2011; 24(9-10):827-9. PubMed ID: 22145486
[TBL] [Abstract][Full Text] [Related]
22. An integration-free iPSC line (MUSIi008-A) derived from a patient with severe hemolytic anemia carrying compound heterozygote mutations in KLF1 gene for disease modeling.
Potirat P; Wattanapanitch M; Viprakasit V; Kheolamai P; Issaragrisil S
Stem Cell Res; 2019 Jan; 34():101344. PubMed ID: 30605837
[TBL] [Abstract][Full Text] [Related]
23. A new missense mutation in the BCKDHB gene causes the classic form of maple syrup urine disease (MSUD).
Miryounesi M; Ghafouri-Fard S; Goodarzi H; Fardaei M
J Pediatr Endocrinol Metab; 2015 May; 28(5-6):673-5. PubMed ID: 25381949
[TBL] [Abstract][Full Text] [Related]
24. [Maple syrup urine disease and gene mutations in twin neonates].
Li T; Wang Y; Li C; Xu WW; Niu FH; Zhang D
Zhongguo Dang Dai Er Ke Za Zhi; 2016 Dec; 18(12):1242-1246. PubMed ID: 27974115
[TBL] [Abstract][Full Text] [Related]
25. Identification of a novel homozygous mutation (S144I) in a Malay patient with maple syrup urine disease.
Ali EZ; Yunus ZM; Desa NM; Hock NL
J Pediatr Endocrinol Metab; 2013; 26(9-10):975-80. PubMed ID: 23729548
[TBL] [Abstract][Full Text] [Related]
26. [Progress of research on Maple syrup disease].
Yang C; Chen T; Lei X; Liu Y; Xu M; Yang D
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Jul; 36(7):737-741. PubMed ID: 31302925
[TBL] [Abstract][Full Text] [Related]
27. Generation of induced pluripotent stem cell line, ICGi007-A, by reprogramming peripheral blood mononuclear cells from a patient with Huntington's disease.
Grigor'eva EV; Malankhanova TB; Surumbayeva A; Minina JM; Morozov VV; Abramycheva NY; Illarioshkin SN; Malakhova AA; Zakian SM
Stem Cell Res; 2019 Jan; 34():101382. PubMed ID: 30658253
[TBL] [Abstract][Full Text] [Related]
28. Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene.
Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Mar; 27():90-94. PubMed ID: 29353703
[TBL] [Abstract][Full Text] [Related]
29. Two novel mutations in the BCKDHB gene that cause maple syrup urine disease.
Han B; Han B; Guo B; Liu Y; Cao Z
Pediatr Neonatol; 2018 Oct; 59(5):515-519. PubMed ID: 29366676
[TBL] [Abstract][Full Text] [Related]
30. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
31. Generation of iPSC lines from peripheral blood mononuclear cells from 5 healthy adults.
Vlahos K; Sourris K; Mayberry R; McDonald P; Bruveris FF; Schiesser JV; Bozaoglu K; Lockhart PJ; Stanley EG; Elefanty AG
Stem Cell Res; 2019 Jan; 34():101380. PubMed ID: 30605840
[TBL] [Abstract][Full Text] [Related]
32. Non-integrating episomal vectors induced pluripotent stem cell line (SDPHi001-A) from a healthy female individual.
Shao J; Shao C; Jin Y; Wang X; Fan H; Yang G
Stem Cell Res; 2021 Oct; 56():102540. PubMed ID: 34547706
[TBL] [Abstract][Full Text] [Related]
33. Peripheral blood derived induced pluripotent stem cells (iPSCs) from a female with familial hypertrophic cardiomyopathy.
Ross SB; Fraser ST; Bagnall RD; Semsarian C
Stem Cell Res; 2017 Apr; 20():76-79. PubMed ID: 28395744
[TBL] [Abstract][Full Text] [Related]
34. Generation of an iPSC line (TSHSUi001-A) from a patient with Peutz-Jeghers syndrome due to STK11 mutation.
Wang T; Zhu K; Yu W; Peng L; Wang H; Wu Q
Stem Cell Res; 2023 Sep; 71():103152. PubMed ID: 37392704
[TBL] [Abstract][Full Text] [Related]
35. Molecular genetics of maple syrup urine disease in the Turkish population.
Gorzelany K; Dursun A; Coşkun T; Kalkanoğlu-Sivri SH; Gökçay GF; Demirkol M; Feyen O; Wendel U
Turk J Pediatr; 2009; 51(2):97-102. PubMed ID: 19480318
[TBL] [Abstract][Full Text] [Related]
36. Generation of iPSC lines from peripheral blood mononuclear cells from five healthy donors.
Vlahos K; Sourris K; Yi Kuah J; Graham A; Suter A; Howden SE; Stanley EG; Elefanty AG
Stem Cell Res; 2023 Jun; 69():103109. PubMed ID: 37150143
[TBL] [Abstract][Full Text] [Related]
37. Four novel mutations of the BCKDHA, BCKDHB and DBT genes in Iranian patients with maple syrup urine disease.
Zeynalzadeh M; Tafazoli A; Aarabi A; Moghaddassian M; Ashrafzadeh F; Houshmand M; Taghehchian N; Abbaszadegan MR
J Pediatr Endocrinol Metab; 2018 Jan; 31(2):205-212. PubMed ID: 29306928
[TBL] [Abstract][Full Text] [Related]
38. Two novel compound heterozygous mutations in the BCKDHB gene that cause the intermittent form of maple syrup urine disease.
Guo Y; Liming L; Jiang L
Metab Brain Dis; 2015 Dec; 30(6):1395-400. PubMed ID: 26239723
[TBL] [Abstract][Full Text] [Related]
39. A non-integrated iPSC line (SDQLCHi042-A) from a boy suffering from familial combined hyperlipidemia with compound heterozygous mutations of lipoprotein lipase gene.
Li Z; Zhang X; Li X; Yang Y; Xin H; Yang X; Liu N; Gai Z; Liu Y
Stem Cell Res; 2021 May; 53():102313. PubMed ID: 34087978
[TBL] [Abstract][Full Text] [Related]
40. In silico prediction of the pathogenic effect of a novel variant of BCKDHA leading to classical maple syrup urine disease identified using clinical exome sequencing.
Fernández-Lainez C; Aláez-Verson C; Ibarra-González I; Enríquez-Flores S; Carrillo-Sanchez K; Flores-Lagunes L; Guillén-López S; Belmont-Martínez L; Vela-Amieva M
Clin Chim Acta; 2018 Aug; 483():33-38. PubMed ID: 29673582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
